PIA-PR 2025-2026 Board of Directors
PIA’s Board of Directors is composed of 10 members represented by the company’s top executive in Puerto Rico. Five members represent the manufacturing sector and five the commercial sector. In addition, there are three ex-officio members: The Operations Director, the legal Counsel, and the Advisor to the Board.
The Executive Committee of the board is composed by:
Executive Commitee
Juan I. Diddi
Chairperson
General Manager Puerto Rico & Caribe
Bristol Myers Squibb
David L. Thompson
Vice Chairperson
Site Head
AbbVie
Brandon P. Paschal
Treasurer
SVP Global Dry Products Operations, President & GM
Lilly del Caribe
Glorimar Torres
Secretary
General Manager
Amgen Commercial Operations
Directors
José Castellote
General Manager
J&J Innovative Medicines
Javier F. Deida
Regional Business Director and Country Lead
Pfizer Biopharmaceutical
Sara M. Miranda
President & General Manager
AstraZeneca Operations/IPR Pharmaceuticals
Iramis Ralat
Executive Director & General Manager
Bristol Myers Squibb
María M. Rivera
Business Director Puerto Rico Market
Organon
Thomas Seewoester
VP Site Operations
Amgen Manufacturing Limited
Past President
Ileana Quiñones
VP & General Manager
J&J Innovative Medicines Supply
Ad Hoc Members
Rafael Castro
VP Operations
Iván Román
Advisor to the Board
Eduardo Negrón Navas
Legal Counsel
